Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-05-31
1998-09-08
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 111, 424 165, 530300, 530328, 530329, 530330, 534 14, A61K 5100, A61M 3614
Patent
active
058041583
ABSTRACT:
Compounds useful for high resolution diagnostic imaging incorporate an imaging agent having a chelator that is linked by a metal-cleavable bond to a ligand that has affinity for a site removed from the site of diagnostic interest. Upon labelling, the ligand is cleaved leaving the labelled imaging agent free to localize at the site of diagnostic interest unhindered, while the ligand and any unlabelled imaging agent is sequestered to the removed site. By sequestering unlabelled imaging agent, the labelled imaging agent does not compete to occupy the site of interest, resulting in images of enhanced resolution.
REFERENCES:
patent: 4421735 (1983-12-01), Haber et al.
patent: 4678667 (1987-07-01), Meavrs et al.
patent: 4946668 (1990-08-01), Daddona et al.
patent: 4980147 (1990-12-01), Fritzberg et al.
patent: 5171563 (1992-12-01), Abrams et al.
patent: 5242679 (1993-09-01), Fritzberg et al.
patent: 5480970 (1996-01-01), Pollak et al.
patent: 5556982 (1996-09-01), Fritzberg et al.
patent: 5569745 (1996-10-01), Goodbody et al.
patent: 5662885 (1997-09-01), Pollak et al.
Jones Dameron
Kight John
Resolution Pharmaceuticals Inc.
LandOfFree
Sequestered imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sequestered imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequestered imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1279416